Complementary mAb Polishing Solutions for Viral Clearance and Aggregate Removal - Register Now!
|Articles|September 18, 2009

InVitria Launches Animal-Origin Free Transferrin

Author(s)Chitra Sethi

Colorado-based InVitria, a division of the biopharmaceutical company Ventria Bioscience, has launched an animal-free recombinant transferrin for use in mammalian cell culture.

Colorado-based InVitria, a division of the biopharmaceutical company Ventria Bioscience, has launched an animal-free recombinant transferrin for use in mammalian cell culture.

The new cell culture supplement, called Optiferrin, which supports cell growth by regulating the amount of iron transported to the cell. Because iron is required for healthy cell culture performance, it is a critical component to reach optimal performance.

Optiferrin addresses the need for animal-free transferrin in many applications including stem cells, primary cells, hybridoma cells, and Chinese hamster ovary cells.

According to the company’s press release, Optiferrin has undergone extensive testing by beta customers, who formulated Optiferrin into their cell culture media and liked the results.


Related to this article

The BioPharm Brief: Room Temperature, RNA, and ADCs
CaseBioscience joins an ARPA-H effort to develop room-temperature cell therapy preservation, Novartis licenses an mRNA-encoded T-cell engager from Abogen, and AstraZeneca, Daiichi Sankyo, and Summit plan to combine Datroway with ivonescimab.